KIGALI, RWANDA, September, 25, 2019 — The Government of Rwanda, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. Centers for Disease Control and Prevention (CDC), and ICAP at Columbia University released new data today that demonstrate Rwanda’s remarkable progress toward achieving HIV epidemic control — particularly in attaining high levels of linkage to treatment and viral load suppression among people living with HIV.
Results from the Rwanda Population-based HIV Impact Assessment (RPHIA) show that 76 percent of all HIV-positive adults, including almost 80 percent of HIV-positive women, have achieved viral load suppression, a widely used measure of effective HIV treatment in a population. This surpasses the Joint United Nations Programme on HIV/AIDS (UNAIDS) target of 73 percent by 2020. Rwanda has made tremendous progress by reaching or exceeding the UNAIDS 90–90–90 targets
external icon
, particularly among women, and nationally by attaining 84–98–90 among adults.
The preliminary survey findings reflect the degree to which Rwanda’s national HIV programs and policies have contributed significantly towards reducing new infections and ensuring people living with HIV are linked to and sustained on HIV treatment. The RPHIA results will also inform the future direction of Rwanda’s efforts to reach epidemic control by closing identified gaps.
“RPHIA preliminary findings highlight the results of national leadership, citizen participation and strong partnerships that characterized the fight against HIV in Rwanda,” said Rwanda Minister of Health, Diane Gashumba, MD. “I am happy with our progress towards achieving 90-90-90 UNAIDS global targets. The remaining gaps identified will require more efforts and sustained collaboration with our partners – I commend the very valuable support from PEPFAR, CDC, ICAP and other research institutions in Rwanda involved in the design, implementation and analysis of these data. We look forward to disseminating the RPHIA results in Kigali next month.”
“We congratulate Rwanda on these remarkable results,” said Ambassador Deborah L. Birx, U.S. Global AIDS Coordinator and U.S. Representative for Global Health Diplomacy. “They prove what’s possible through the combination of political leadership, proactive policies, data-driven programs, and community engagement—all essential ingredients for reaching HIV/AIDS epidemic control.”
“Congratulations to the government and people of Rwanda for their dedication to stopping their HIV epidemic and linking more than 97 percent of those diagnosed into care. The success they have achieved in surpassing the UNAIDS 2020 goal demonstrates the power of effective HIV treatment and care,” said CDC Director Robert Redfield, M.D. “CDC remains committed to supporting Rwanda and other nations as they respond to the HIV pandemic and save lives.”
“Rwanda has already reached and exceeded the global 2020 HIV targets, and this is a testament to the Government of Rwanda’s commitment to confronting its HIV epidemic” noted Wafaa El-Sadr, MD, MPH, MPA, Director of ICAP. “The RPHIA results illustrate the importance of population-based surveys in measuring the progress and impact of national HIV programs and policies.”
From October 2018-March 2019, RPHIA reached over 11,000 households across the country, surveying more than 30,000 adults aged 15-64 years, and over 9,000 young adolescents aged 10-14 years. The survey provided home-based HIV testing and counseling services, with return of results and linkage to care for those who tested HIV-positive.
The key results released today include information on the percentage of people living with HIV (prevalence), the number of new HIV infections occurring each year (incidence), and the percentage of people with low levels of virus in their blood (viral load suppression), described by age, sex, and geographic variation.
Some key findings of the RPHIA 2018-19 survey include:
HIV prevalence among adults, aged 15-49 years, was 2.6 percent, and 3 percent among those aged 15-64 years indicating that approximately 210,200 adults in Rwanda were living with HIV
HIV prevalence was higher in women (3.7 percent) than men (2.2 percent)
HIV prevalence was 1.9 times higher in urban areas compared to rural areas
The annual incidence of HIV among adults was 0.08 percent, corresponding to approximately 5,400 new cases of HIV per year in Rwanda
Among all adults living with HIV, 76 percent had suppressed viral loads – 79.1 percent among women and 70.5 percent among men.
In relation to UNAIDS 90-90-90 targets, when combining self-reported and laboratory data, results indicated:
83.8 percent of adults living with HIV were aware of their status, based on self-reporting or the detection of antiretrovirals (ARVs) in participants’ blood samples
Of adults who knew their status, 97.5 percent were on ART, based on self-reporting or the detection of ARVs
Of adults who had detectable ARVs or reported current use of ARVs, 90.1 percent had Viral Load Suppression
The Rwanda Biomedical Center will publish RPHIA summary sheet on October 22 and they will be available on the PHIA website at https://phia.icap.edu/rwandaexternal icon
external icon
The final report will be available in the coming months.
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.